Provided by Tiger Trade Technology Pte. Ltd.

Rezolute, Inc.

4.01
-0.0600-1.47%
Post-market: 3.99-0.0200-0.50%19:30 EDT
Volume:1.65M
Turnover:6.64M
Market Cap:386.13M
PE:-5.37
High:4.20
Open:4.13
Low:3.97
Close:4.07
52wk High:11.46
52wk Low:1.07
Shares:96.29M
Float Shares:72.51M
Volume Ratio:1.05
T/O Rate:2.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7467
EPS(LYR):-0.7467
ROE:-59.04%
ROA:-35.32%
PB:3.83
PE(LYR):-5.37

Loading ...

Rezolute upgraded to Outperform from Market Perform at Citizens

TIPRANKS
·
Jun 03

Rezolute price target raised to $6 from $5 at BTIG

TIPRANKS
·
Jun 03

Analysts Are Bullish on These Healthcare Stocks: Rezolute (RZLT), Relay Therapeutics (RLAY)

TIPRANKS
·
Jun 03

Rezolute price target raised to $14 from $10 at Maxim

TIPRANKS
·
Jun 03

Rezolute Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
Jun 02

BUZZ-U.S. STOCKS ON THE MOVE-Dollar General, Vera, Amtech Systems

Reuters
·
Jun 02

Rezolute Says 6 Participants Meet Responder Criterion in Phase 3 Tumor Hyperinsulinism Trial

MT Newswires Live
·
Jun 02

BUZZ-U.S. STOCKS ON THE MOVE-Microchip Technology, Marvell Technology, Generac

Reuters
·
Jun 02

BUZZ-Rezolute climbs after positive trial results for low blood sugar treatment

Reuters
·
Jun 02

Rezolute says 6 of 8 patients meet primary endpoint in Phase 3 upLIFT trial of ersodetug for tumor hyperinsulinism

Reuters
·
Jun 02

Rezolute - Topline Results for Uplift Study Expected in Second Half of 2026

THOMSON REUTERS
·
Jun 02

Rezolute - All 6 Responders Achieve Complete Discontinuation of Intravenous Glucose Requirements

THOMSON REUTERS
·
Jun 02

Rezolute - 6 of 8 Participants Meet Primary Endpoint Responder Criterion in Uplift Study

THOMSON REUTERS
·
Jun 02

Rezolute Announces Positive Interim Data for Its Phase 3 Uplift Study of Ersodetug in Tumor Hyperinsulinism

THOMSON REUTERS
·
Jun 02

Rezolute Is Maintained at Buy by Maxim Group

Dow Jones
·
May 15

Rezolute price target raised to $10 from $4 at Maxim

TIPRANKS
·
May 14

Maxim Group Keeps Their Buy Rating on Rezolute (RZLT)

TIPRANKS
·
May 14

High Growth Tech Stocks in US for May 2026

Simply Wall St.
·
May 14

Rezolute Q3 EPS $(0.16), Inline

Benzinga Earnings
·
May 13

Rezolute Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13